Gencor Industries In (GENC) 17.65 $GENC 40.5% Return

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gencor Industries In (GENC) 17.65 $GENC

40.5% Return Seen to Date on SmarTrend Gencor Industries Call (GENC)
Comtex SmarTrend(R) - Thu Jul 28, 1:08PM CDT
SmarTrend identified an Uptrend for Gencor Industries (NASDAQ:GENC) on February 10th, 2016 at $12.73. In approximately 6 months, Gencor Industries has returned 40.53% as of today's recent price of $17.89.
GENC: 17.65 (+0.05)

Gencor Announces 50% Stock Dividend
GlobeNewswire - Mon Jul 11, 9:14AM CDT
Gencor Industries, Inc., (NASDAQ:GENC) (the "Company" announced that its Board of Directors has approved a three-for-two split of the Company's Common and Class B stock to be effected in the form of a 50% stock dividend. As a result, shareholders will receive one additional share of Common or Class B stock for every two shares they held of the respective class of stock as of the record date. These shares will be distributed on August 1, 2016, to shareholders of record as of the end of business on July 22, 2016.
GENC: 17.65 (+0.05)

Gencor posts 2Q profit
Automated Insights - Mon May 09, 6:36PM CDT
ORLANDO, Fla. (AP) _ Gencor Industries Inc. (GENC) on Monday reported fiscal second-quarter profit of $1.6 million.
GENC: 17.65 (+0.05)

Gencor Releases Second Quarter Fiscal 2016 Results
GlobeNewswire - Mon May 09, 3:30PM CDT
Gencor Industries, Inc. (Nasdaq:GENC) announced today net revenue for the quarter ended March 31, 2016 increased 60.5% to $22.1 million from $13.8 million for the quarter ended March 31, 2015. Gross margin was 24.6% for the quarter ended March 31, 2016 compared with 26.4% for the quarter ended March 31, 2015. Selling, general and administrative ("SG&A" expenses increased $414,000 to $2,190,000 for the quarter ended March 31, 2016, from $1,776,000 for the quarter ended March 31, 2015. Increased staffing along with higher sales commissions contributed to the increased SG&A expenses. Operating income for the quarter ended March 31, 2016 was $2.9 million compared to $1.5 million for the quarter ended March 31, 2015.
GENC: 17.65 (+0.05)

Gencor Industries Shares Up 13.9% Since SmarTrend's Buy Recommendation (GENC)
Comtex SmarTrend(R) - Tue Mar 08, 10:15AM CST
SmarTrend identified an Uptrend for Gencor Industries (NASDAQ:GENC) on February 10th, 2016 at $12.73. In approximately 4 weeks, Gencor Industries has returned 13.90% as of today's recent price of $14.50.
GENC: 17.65 (+0.05)

Gencor Releases First Quarter Fiscal 2016 Results
GlobeNewswire - Wed Feb 10, 8:56AM CST
Gencor Industries, Inc. (Nasdaq:GENC) announced today net revenues increased 111% to $13.3 million for the quarter ended December 31, 2015 compared to $6.3 million for the quarter ended December 31, 2014. Gross margins increased significantly from 5.5% for the quarter ended December 31, 2014 to 24.8% for the quarter ended December 31, 2015, due to improved productivity, increased revenues and cost absorption, process improvements, and lower commodity prices. Product engineering and development expenses increased $53,000 to $382,000 for the quarter ended December 31, 2015 due to increased staffing and payroll. Selling, general and administrative expenses increased $135,000 or 8.2% to $1,785,000 for the quarter ended December 31, 2015. Sales commissions and other operating expenses increased due to the higher revenues. Operating income for the quarter ended December 31, 2015 was $1.1 million, compared to an operating loss of $(1.6) million for the quarter ended December 31, 2014.
GENC: 17.65 (+0.05)

Gencor Industries Has Returned 24.2% Since SmarTrend Recommendation (GENC)
Comtex SmarTrend(R) - Wed Jan 13, 10:00AM CST
SmarTrend identified an Uptrend for Gencor Industries (NASDAQ:GENC) on October 16th, 2015 at $9.95. In approximately 3 months, Gencor Industries has returned 24.22% as of today's recent price of $12.36.
GENC: 17.65 (+0.05)

16.3% Return Seen to Date on SmarTrend Gencor Industries Call (GENC)
Comtex SmarTrend(R) - Wed Jan 06, 9:31AM CST
SmarTrend identified an Uptrend for Gencor Industries (NASDAQ:GENC) on October 16th, 2015 at $9.95. In approximately 3 months, Gencor Industries has returned 16.30% as of today's recent price of $11.57.
GENC: 17.65 (+0.05)

Shares of GENC Up 16.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Dec 28, 9:53AM CST
SmarTrend identified an Uptrend for Gencor Industries (NASDAQ:GENC) on October 16th, 2015 at $9.95. In approximately 2 months, Gencor Industries has returned 16.58% as of today's recent price of $11.60.
GENC: 17.65 (+0.05)

29.1% Return Seen to Date on SmarTrend Gencor Industries Call (GENC)
Comtex SmarTrend(R) - Thu Dec 10, 4:49PM CST
SmarTrend identified an Uptrend for Gencor Industries (NASDAQ:GENC) on October 16th, 2015 at $9.95. In approximately 2 months, Gencor Industries has returned 29.15% as of today's recent price of $12.85.
GENC: 17.65 (+0.05)

Gencor reports 4Q loss
Automated Insights - Tue Dec 08, 1:15PM CST
ORLANDO, Fla. (AP) _ Gencor Industries Inc. (GENC) on Tuesday reported a loss of $2.2 million in its fiscal fourth quarter.
GENC: 17.65 (+0.05)

Gencor Releases Fourth Quarter and Fiscal Year 2015 Results
GlobeNewswire - Tue Dec 08, 12:20PM CST
Gencor Industries, Inc., (NASDAQ:GENC) announced today net revenue for the quarter ended September 30, 2015 increased 69.4% to $8.3 million compared to $4.9 million for the quarter ended September 30, 2014. Gross margin as a percentage of net revenue increased 110.8% to 13.7% for the quarter ended September 30, 2015 from 6.5% for the quarter ended September 30, 2014. The increase in gross margins was due to higher revenue and a reduction in raw material costs.
GENC: 17.65 (+0.05)

Equity Market Movement at a Glance - Research on Ultralife, First Acceptance, Titan Pharmaceuticals and Gencor Industries
ACCESSWIRE - Wed Dec 02, 7:15AM CST
NEW YORK, NY / ACCESSWIRE / December 02, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Ultralife Corp. (NASDAQ: ULBI), First Acceptance Corp. (NYSE: FAC), Titan Pharmaceuticals Inc. (NASDAQ: TTNP) and Gencor Industries Inc. (NASDAQ: GENC). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
ULBI: 4.21 (-0.14), GENC: 17.65 (+0.05), TTNP: 4.99 (+0.03), FAC: 1.71 (+0.19)

8.4% Return Seen to Date on SmarTrend Gencor Industries Call (GENC)
Comtex SmarTrend(R) - Tue Aug 25, 9:55AM CDT
SmarTrend identified a Downtrend for Gencor Industries (NASDAQ:GENC) on August 6th, 2014 at $10.18. In approximately 13 months, Gencor Industries has returned 8.40% as of today's recent price of $9.32.
GENC: 17.65 (+0.05)

Gencor Releases Third Quarter Fiscal 2015 Results
GlobeNewswire - Wed Aug 05, 12:53PM CDT
Gencor Industries, Inc. (Nasdaq:GENC) announced today net revenue for the quarter ended June 30, 2015 increased 3.7% to $10.9 million from $10.6 million for the quarter ended June 30, 2014. Gross margin increased to 21.9% for the quarter ended June 30, 2015 from 21.6% for the quarter ended June 30, 2014. Selling, general and administrative expenses increased $146,000 to $1,703,000 for the quarter ended June 30, 2015. Operating income for the quarter ended June 30, 2015 was $345,000 compared to $372,000 for the quarter ended June 30, 2014.
GENC: 17.65 (+0.05)

Gencor reports lower net income of USD1.2m in Q2 fiscal 2015
M2 - Mon May 11, 5:33AM CDT
Machinery company Gencor Industries (NasdaqGM:GENC) disclosed on Friday that it recorded net income of USD1.2m (USD0.12 per basic and diluted share) for the second quarter ended 31 March 2015.
GENC: 17.65 (+0.05)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cargo Drones to Skyrocket with $9.14B Value by 2031

Updated Category News Views 141

Riding the Drone Wave I tell you what, folks, the whole business of cargo drones is getting frickin' interesting. These flying gizmos, once dismissed as science fiction, are now barging their way into logistics discussions like an uninvited guest who's too worthwhile to ignore. MarketsandMarkets™ reckons this market's about to smash through the $9 billion ceiling by...

Continue Reading
SiteOne Joins S&P SmallCap 600 Amid KKR's Integer Buyout

Updated Category News Views 99

Changes on the SmallCap Horizon Starting off, SiteOne Landscape Supply (NYSE: SITE) is hopping onto the S&P SmallCap 600 bandwagon. This shift activates just as the market revs up on November 19, 2026. SiteOne is stepping in as Integer Holdings Corp. (NYSE: ITGR) makes its grand exit, a move prompted by a significant acquisition by KKR & Co. Inc. (NYSE: KKR). KKR’s...

Continue Reading
Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 113

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading
LA Hospitals Shine in Pulmonary Excellence Nationwide

Updated Category News Views 103

Los Angeles Community Hospitals' Recent Recognition You ever stroll into a hospital and wonder if you’re really getting the best care? Well, the folks over at Los Angeles Community Hospitals, covering LA, Norwalk, and Bellflower, just got a big nod from Healthgrades—yeah, the site everyone's checking to find decent healthcare options. They’ve landed among the top...

Continue Reading
Jones Soda Expands into Nutrition with UCAN Deal

Updated Category News Views 176

Well, Jones Soda Co. (CSE: JSDA) is stirring the pot with its recent move to acquire the UCAN functional nutrition assets. Popped the news on November 12, 2026, and it turns out they've shelled out a cool $700,000 in cash and taken on $500,000 in liabilities for the privilege. This isn't some casual shuffle of dollars and cents—this one's a strategic gambit aimed at...

Continue Reading
Hermes AI: A New Era in Market Analysis?

Updated Category News Views 88

Revolution or Just Another App? In a world where stock market insights are as cryptic as hieroglyphs to the average Joe, here comes the Hermes AI Analyzer, breaking onto the scene and promising to translate Wall Street's complex lingo into plain, simple language. It's the brainchild of Turkish engineer Umut Tugrul, who has spent decades in the trenches of software...

Continue Reading
Disney+ Teams Up with Tiff's: Blue Cookie Debut

Updated Category News Views 91

A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...

Continue Reading
Nord Anglia Schools Shine with 13 Tes Awards Nominations

Updated Category News Views 154

Nord Anglia's Moment of Glory at Tes Awards You think you know the big players in the educational game? Well, guess again. Nord Anglia's come out swinging with a whopping 13 finalist nominations at the 2026 Tes Awards for International Schools. It ain't easy making waves in the education sector, but these folks are showing they've got what it takes to turn heads, not just...

Continue Reading
equipifi's BNPL Shop: New Ammo for Credit Unions

Updated Category News Views 87

equipifi's 'Shop': The Big Play in Banking Look, here’s the deal—equipifi just lobbed a new grenade into the finance battlefield, arming credit unions and community banks with 'Shop', their own Buy Now, Pay Later (BNPL) platform. The goal? To put them toe-to-toe with the big fintech wolves—something these smaller guys desperately needed. It's a meaty move, no...

Continue Reading
Apotex Enters U.S. Market with Axitinib Tablets Launch

Updated Category News Views 114

Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...

Continue Reading

Top 5 Most Recently Viewed Articles

LXP Industrial Trust's Strong First Quarter Performance Revealed

Updated Category News Views 197

LXP Industrial Trust Reports Strong Financial Results Today, LXP Industrial Trust (NYSE: LXP), a real estate investment trust specializing in Class A warehouse and distribution facilities, outlines its robust performance for the first quarter of 2025. Key financial figures and strategic developments reflect the company's growth trajectory in the dynamic real estate...

Continue Reading
AI in Diagnostics: A Bright Future with Rapid Growth Ahead

Updated Category News Views 314

AI in Diagnostics Market Overview In recent years, the integration of Artificial Intelligence (AI) into the diagnostics sector has shown remarkable potential. As healthcare progresses, the reliance on AI technology for early disease detection and diagnosis is becoming increasingly vital. The current healthcare landscape is witnessing an upsurge in the occurrence of...

Continue Reading
Fund Manager Scott Bessent Bets Big on Trump's Economic Policies

Updated Category News Views 312

Scott Bessent's Strategic Bet on Trump As a prominent figure in the investment community, Scott Bessent's journey has seen significant highs and lows. Currently, he finds himself in a pivotal moment, leveraging the political climate surrounding President-elect Donald Trump to make strategic moves that might reshape his career and the future of Key Square Capital...

Continue Reading
Mifflinburg Bancorp and Northumberland Bancorp Unite for Growth

Updated Category News Views 161

Mifflinburg Bancorp and Northumberland Bancorp Unite Mifflinburg Bancorp, Inc. (OTCPK: MIFF) and Northumberland Bancorp (OTCPK: NUBC) have officially revealed a strategic merger that is poised to transform the financial landscape. This merger, described as a union of equals, will create a new entity with significant resources aimed at improving capabilities and...

Continue Reading
ZTE's CDO Unveils Future of Intelligence at Key Shanghai Event

Updated Category News Views 215

ZTE's Vision for Intelligent Evolution at MWC25 ZTE Corporation (0763.HK / 000063.SZ), a prominent provider of information and communication technology solutions, made a significant impact at MWC25 in Shanghai. During this year’s event, Cui Li, Chief Development Officer of ZTE, captivated an audience during her keynote address titled "Digital and Intelligent Evolution:...

Continue Reading